doi: 10.1038/jid.2013.464.
Epub 2013 Nov 11.
Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009
Affiliations
- PMID: 24202232
- PMCID: PMC3961558
- DOI: 10.1038/jid.2013.464
Item in Clipboard
Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009
J Invest Dermatol.
2014 Apr.
No abstract available
Conflict of interest statement
The authors declare no conflict of interests.
Similar articles
-
Incidence and prevalence of alopecia areata according to subtype: a nationwide, population-based study in South Korea (2006-2015).Br J Dermatol. 2019 Nov;181(5):1092-1093. doi: 10.1111/bjd.18145. Epub 2019 Aug 6. Br J Dermatol. 2019. PMID: 31102412 No abstract available.
-
Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989.Mayo Clin Proc. 1995 Jul;70(7):628-33. doi: 10.4065/70.7.628. Mayo Clin Proc. 1995. PMID: 7791384
-
Increasing prevalence of alopecia areata in South Korea.J Dermatol. 2019 Sep;46(9):e331-e332. doi: 10.1111/1346-8138.14863. Epub 2019 Mar 25. J Dermatol. 2019. PMID: 30908740 No abstract available.
-
Genetics of alopecia areata.Australas J Dermatol. 2000 Nov;41(4):213-8. doi: 10.1046/j.1440-0960.2000.00439.x. Australas J Dermatol. 2000. PMID: 11105363 Review.
-
Alopecia Areata. Current situation and perspectives.Arch Argent Pediatr. 2017 Dec 1;115(6):e404-e411. doi: 10.5546/aap.2017.eng.e404. Arch Argent Pediatr. 2017. PMID: 29087123 Review. English, Spanish.
Cited by
-
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies.Front Pharmacol. 2022 Aug 24;13:950450. doi: 10.3389/fphar.2022.950450. eCollection 2022. Front Pharmacol. 2022. PMID: 36091777 Free PMC article.
-
Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide.Int J Dermatol. 2018 Sep;57(9):1021-1034. doi: 10.1111/ijd.13904. Epub 2018 Jan 29. Int J Dermatol. 2018. PMID: 29377079 Free PMC article. Review.
-
Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.Cureus. 2025 Apr 18;17(4):e82536. doi: 10.7759/cureus.82536. eCollection 2025 Apr. Cureus. 2025. PMID: 40385726 Free PMC article.
-
Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota.Clin Exp Immunol. 2022 Dec 15;210(2):175-186. doi: 10.1093/cei/uxac088. Clin Exp Immunol. 2022. PMID: 36200950 Free PMC article.
-
The association between alopecia areata and anxiety, depression, schizophrenia, and bipolar disorder: a population-based study.Arch Dermatol Res. 2022 Jul;314(5):463-468. doi: 10.1007/s00403-021-02247-6. Epub 2021 Jun 5. Arch Dermatol Res. 2022. PMID: 34089375
References
-
- Finner AM. Alopecia areata: Clinical presentation, diagnosis, and unusual cases. Dermatol Ther. 2011;24:348–54. - PubMed
-
- Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366:1515–25. - PubMed
-
- Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20:1055–60. - PubMed
-
- Kavak A, Yesildal N, Parlak AH, Gokdemir G, Aydogan I, Anul H, et al. Alopecia areata in Turkey: demographic and clinical features. J Eur Acad Dermatol Venereol. 2008;22:977–81. - PubMed
-
- Kyriakis KP, Paltatzidou K, Kosma E, Sofouri E, Tadros A, Rachioti E. Alopecia areata prevalence by gender and age. J Eur Acad Dermatol Venereol. 2009;23:572–3. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
